Skip to content
DataLookout
Menu

SK Life Science, Inc. clinical trial pipeline

Get alerts when SK Life Science, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-05

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor: Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures Trial completed SK Life Science, Inc.Phase 3 NCT05067634
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 1
1
Phase 3
1
Phase 4
1

Disease areas by active trials

Get alerts when SK Life Science, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free